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Introduction: Raynaud Phenomenon (RP) and digital ulcers (DU) are the main clinical 
manifestation of vasculopathy secondary to Juvenile Systemic Sclerosis (jSSc). 
Accepted treatment for RP is calcium channel blockers. Iloprost is indicated if active 
ulcers are present or if RP is refractory to treatment. 
Objectives: - The aim of this study was to access the safety and efficacy of ambulatory 
treatment with intravenous prostanoides in children with RP and DU secondary to jSSc. 
Methods: Three patients with jSSc and active digital ulcers were treated with 
intravenous iloprost . Our protocol establishes two treatments in the cold months: one 
in the beginning and the second 3 months later, of a continuous five day intravenous 
infusion(iv) of iloprost in a dose of 0.4-0,6 mg/kg/min perfusion through an 
elastomeric pump. 
Results: Since 2007 we treated three patients with jSSc and active digital ulcers: two 
girls, 12 and 13 years, and a boy of 18 months old at time of first treatment. A total of 
19 treatments of iv. iloprost were done, 15 of these in ambulatory basis with the 
elastomeric pump. 
Outcomes were good with a reduced number and severity of RP attacks in all patients, 
and reduced pain associated with RP and DU. No disabling or severe side effects were 
observed. Two patients, the girls, had no more active digital ulcers after the second 
treatment with a follow-up of 2 and 3 years respectively. One patient, male, has 
recurrent digital ulcers, but number has decreased from 4 to 1 not interfering with 
daily activities. 
Conclusion: Iloprost iv. perfusion with the elastomeric pump at ambulatory is a safe 
and effective treatment for patients with refractory RP to calcium channel blockers 
and in patients with digital ulcers. The authors suggest two treatments in the winter 
season with reduction of number and severity of R and ulcer healing. 
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